Department of Anesthesiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China.
Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
J Cardiothorac Vasc Anesth. 2020 Jun;34(6):1397-1401. doi: 10.1053/j.jvca.2020.03.026. Epub 2020 Mar 30.
The outbreak of a new coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) in China in December 2019 has brought serious challenges to disease prevention and public health. Patients with severe coronavirus disease 2019 (COVID-19) who undergo cardiovascular surgery necessitate extremely high demands from anesthesia personnel, and face high risks of mortality and morbidity. Based on the current understanding of COVID-19 and the clinical characteristics of cardiovascular surgical patients, the authors provide anesthesia management guidelines for cardiovascular surgery along with the prevention and control of COVID-19.
2019 年 12 月，中国新发冠状病毒（严重急性呼吸综合征冠状病毒 2 [SARS-CoV-2]）的爆发给疾病预防和公共卫生带来了严峻挑战。患有严重 2019 年冠状病毒病（COVID-19）的患者需要接受心血管手术，这对麻醉人员提出了极高的要求，并且面临着高死亡率和发病率的风险。基于对 COVID-19 的现有认识和心血管外科患者的临床特征，作者为心血管外科手术提供了麻醉管理指南以及 COVID-19 的预防和控制措施。
